Your doctor may start you on a lower dose and increase it gradually while closely monitoring your blood pressure
As hunger continues to be suppressed, weight loss tends to become more consistent
Obesity 30(4):841857 Coulter AA, Rebello CJ, Greenway FL (2018) Centrally acting drugs for obesity: past, present, and future
(7.2 ) Concomitant Use with an Insulin Secretagogue (e.g., Sulfonylurea) or with Insulin OZEMPIC stimulates insulin release in the presence of elevated blood glucose concentrations
Wegovy (semaglutide) Injector is a prescription medication used to treat obesity in adults who have a body mass index (BMI) of 30 kg/m or greater, or in adults with a BMI of 27 kg/m or greater who also have at least one weight-related medical condition, such as high blood pressure, type 2 diabetes, or high cholesterol